title: Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging.
abstract: Mouse models of Huntington's disease (HD) that recapitulate some of the phenotypic features of human HD, play a crucial role in investigating disease mechanisms and testing potential therapeutic approaches. Longitudinal studies of these models can yield valuable insights into the temporal course of disease progression and the effect of drug treatments on the progressive phenotypes. Atrophy of the brain, particularly the striatum, is a characteristic phenotype of human HD, is known to begin long before the onset of motor symptoms, and correlates strongly with clinical features. Elucidating the spatial and temporal patterns of atrophy in HD mouse models is important to characterize the phenotypes of these models, as well as evaluate the effects of neuroprotective treatments at specific time frames during disease progression. In this study, three dimensional in vivo magnetic resonance imaging (MRI) and automated longitudinal deformation-based morphological analysis was used to elucidate the spatial and temporal patterns of brain atrophy in the R6/2 and N171-82Q mouse models of HD. Using an established MRI-based brain atlas and mixed-effects modeling of deformation-based metrics, we report the rates of progression and region-specificity of brain atrophy in the two models. Further, the longitudinal analysis approach was used to evaluate the effects of sertraline and coenzyme Q(10) (CoQ(10)) treatments on progressive atrophy in the N171-82Q model. Sertraline treatment resulted in significant slowing of atrophy, especially in the striatum and frontal cortex regions, while no significant effects of CoQ(10) treatment were observed. Progressive cortical and striatal atrophy in the N171-82Q mice showed significant positive correlations with measured functional deficits. The findings of this report can be used for future testing and comparison of potential therapeutics in mouse models of HD.
authors.affiliation: Division of NMR Research, Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. maggarw2@jhu.edu
authors.forename: Manisha
authors.initials: M
authors.lastname: Aggarwal
authors.forename: Wenzhen
authors.initials: W
authors.lastname: Duan
authors.forename: Zhipeng
authors.initials: Z
authors.lastname: Hou
authors.forename: Neal
authors.initials: N
authors.lastname: Rakesh
authors.forename: Qi
authors.initials: Q
authors.lastname: Peng
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Ross
authors.forename: Michael I
authors.initials: MI
authors.lastname: Miller
authors.forename: Susumu
authors.initials: S
authors.lastname: Mori
authors.forename: Jiangyang
authors.initials: J
authors.lastname: Zhang
mesh_terms: D000818:Animals; D001284:Atrophy / Q000473:pathology / Q000503:physiopathology; D001921:Brain / Q000473:pathology* / Q000503:physiopathology; D001931:Brain Mapping / Q000379:methods*; D004195:Disease Models, Animal; D006816:Huntington Disease / Q000473:pathology* / Q000503:physiopathology; D021621:Imaging, Three-Dimensional; D008279:Magnetic Resonance Imaging / Q000379:methods*; D051379:Mice; D008822:Mice, Transgenic; D016133:Polymerase Chain Reaction